3 Results for "

YX-02-030

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "YX-02-030" in MCE Product Catalog:

Cat. No.: HY-158684
CAS No.: 3049076-98-1
Purity:  99.86%
Research Areas:  

Cancer

YX-02-030 is a VHL-dependent MDM2 PROTAC degrader with a Kd of 35 nM. YX-02-030 recruits the VHL E3 ligase to form a ternary complex, leading to ubiquitination and proteasome-mediated degradation of MDM2. YX-02-030 inhibits MDM2-p53 and VHL-HIF1α binding with IC50 values of 63 and 1350 nM. YX-02-030 activates TAp73, upregulates p53 family target genes and induces apoptosis. YX-02-030 demonstrates on-target efficacy in TNBC xenograft-bearing mice, extending survival without normal cell toxicity .
loading...
    loading...
Cat. No.: HY-158685
CAS No.: 2360561-90-4
Target:  

MDM-2/p53

Research Areas:  

Cancer

RG7112D is a potent MDM2 inhibitor with IC50s of 11 nM and >10000 nM and for MDM2-p53 and VHL-HIF1α by binding HTRF assay, respectively. RG7112D is coupled by an amide bond to VHL-Amine, resulting in a bi-functional molecule, YX-02-030. YX-02-03, a MDM2-PROTAC, potently inhibits MDM2-p53 binding (HTRF IC50=63nM). RG7112D can stabilize MDM2 protein and increase p53 protein levels .
loading...
    loading...
Cat. No.: HY-158684A
CAS No.: 3049077-01-9
Target:  

Drug Isomer

Research Areas:  

Cancer

(4R,5S)-YX-02-030 is an isomer of YX-02-030 (HY-158684). YX-02-030 is a PROTAC MDM2 degrader .
loading...
    loading...